HUMAN PAPILLOMAVIRUS
Clinical trials for HUMAN PAPILLOMAVIRUS explained in plain language.
Never miss a new study
Get alerted when new HUMAN PAPILLOMAVIRUS trials appear
Sign up with your email to follow new studies for HUMAN PAPILLOMAVIRUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New HPV test aims to bring screening to more people
Diagnosis Recruiting nowThis study is testing a new point-of-care diagnostic test for HPV, called the Rice HPV test, to see if it works as well as standard tests. Researchers at MD Anderson Cancer Center will enroll 600 people with a cervix aged 21 or older. The goal is to develop a test that requires l…
Matched conditions: HUMAN PAPILLOMAVIRUS
Sponsor: M.D. Anderson Cancer Center • Aim: Diagnosis
Last updated Jun 27, 2026 12:35 UTC
-
Could 2 HPV vaccine doses be enough for women 27-45? new trial aims to find out.
Prevention Recruiting nowThis study compares the immune response from 2 doses versus the standard 3 doses of the HPV vaccine in women aged 27-45. About 618 participants will be randomly assigned to receive either 2 or 3 doses, and their antibody levels will be checked over 12 months. If 2 doses prove non…
Matched conditions: HUMAN PAPILLOMAVIRUS
Phase: PHASE4 • Sponsor: The University of Texas Medical Branch, Galveston • Aim: Prevention
Last updated Jun 27, 2026 07:53 UTC
-
Scientists hunt for genetic clues to severe HPV infections
Knowledge-focused Recruiting nowThis study is for people aged 3 and older who have severe, recurring HPV-related warts or lesions that don't respond to standard treatments. Researchers want to learn why some people get sicker from HPV than others by studying their genes and immune systems. Participants will pro…
Matched conditions: HUMAN PAPILLOMAVIRUS
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC